Literature DB >> 20548309

Patient advocacy groups: let's stick together.

Tamar Nijsten, Paul R Bergstresser.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20548309     DOI： 10.1038/jid.2010.131

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  2 in total

1.  Patient attitudes and understanding about biosimilars: an international cross-sectional survey.

Authors:  Ira Jacobs; Ena Singh; K Lea Sewell; Ahmad Al-Sabbagh; Lesley G Shane
Journal:  Patient Prefer Adherence       Date:  2016-05-26       Impact factor: 2.711

2.  Principles for interactions with biopharmaceutical companies: the development of guidelines for patient advocacy organizations in the field of rare diseases.

Authors:  Susan Stein; Elizabeth Bogard; Nicole Boice; Vivian Fernandez; Tessa Field; Alan Gilstrap; Susan R Kahn; Jane Larkindale; Toni Mathieson
Journal:  Orphanet J Rare Dis       Date:  2018-01-22       Impact factor: 4.123
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.